Avantor names Ludovic Brellier EVP Bioscience & Medtech Products; Gourdier to depart by Dec 2026

Avantor, Inc.

Ludovic Brellier appointed EVP, Bioscience & Medtech Products and Chief Transformation Officer effective May 1, 2026.
Brellier joins from Danaher, where he was President of Cytiva’s Hardware Solutions; will lead Revival Management Office.
Current EVP Benoit Gourdier will transition to a support role and depart Avantor no later than December 31, 2026.
Brellier to oversee BMP business growth, operational performance, and enterprise transformation initiatives.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.